跳至主要内容
临床试验/NCT01734135
NCT01734135已完成不适用

Trial of Provider Notification for Patients With High B-type Natriuretic Peptide and no Imaging to Identify Unsuspected Heart Failure.

VA Palo Alto Health Care System2 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2010年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
115
试验地点
2
主要终点
Measurement of left ventricular ejection fraction

研究概览

简要总结

This proposal examines use of a clinical reminder to the primary provider of patient with a high B type natriuretic peptide but no prior imaging.

Electrical Medical Record-based Intervention to Determine whether Clinical Reminders Improve Heart Failure Management in Patients with High BNP Values and Unknown LVEF.

详细描述

Rationale: B type natriuretic peptide is known to be elevated (> 100 pg/ml) in patients with heart failure. Furthermore, treatments are available to improve survival and reduce hospitalization if the left ventricular ejection fraction (LVEF) is < 40%. Accordingly, guidelines recommend an LVEF measure for patients with suspected heart failure. Prior work has demonstrated that patients with high BNP values do not always have a measure of left ventricular ejection.

Hypothesis

A reminder to patients with BNP and no imaging may prompt providers to order appropriate imaging potentially leading to 1) identification of unsuspected depressed ejection fraction and 2) more appropriate treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BNP >= 200 pg/ml in last 2 months

排除标准

  • Measure of LVEF in the last 12 months
  • Last measure of LVEF < 40%

结局指标

主要结局

Measurement of left ventricular ejection fraction

时间窗: 6 months after randomization

numerator: Measurement of left ventricular ejection fraction within 6 months of randomization. denominator: All randomized patients

次要结局

  • Treatment of Low LVEF(6 months following randomization)
  • Identification of LVEF < 40%(6 months following randomizaiton)

研究者

发起方
VA Palo Alto Health Care System
申办方类型
Fed
责任方
Principal Investigator
主要研究者

Paul Heidenreich

Investigator

VA Palo Alto Health Care System

研究点 (2)

Loading locations...

相似试验